The use of in vivo zebrafish assays in drug toxicity screening

By Eimon Peter M   Rubinstein Amy L  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 4, 2009-04 ,pp. : 393-401

Informa Healthcare

Access to resources Recommend Favorite

In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery

By Darvesh Altaf S   Carroll Richard T   Geldenhuys Werner J   Gudelsky Gary A   Klein Jochen   Meshul Charles K   Van der Schyf Cornelis J  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 2, 2011-02 ,pp. : 109-127

Informa Healthcare

Access to resources Recommend Favorite

Rebinding: or why drugs may act longer in vivo than expected from their in vitro target residence time

By Vauquelin Georges  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 10, 2010-10 ,pp. : 927-941

Informa Healthcare

Access to resources Recommend Favorite

pH-Dependent Dissolution in Vitro and Absorption in Vivo of Weakly Basic Drugs: Development of a Canine Model

By Zhou Rong   Moench Paul   Heran Christopher   Lu Xujin   Mathias Neil   Faria Teresa N.   Wall Doris A.   Hussain Munir A.   Smith Ronald L.   Sun Duxin  

Pharmaceutical Research, Vol. 22, Iss. 2, 2005-02 ,pp. : 188-192

Springer Publishing Company

Access to resources Recommend Favorite

Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models

By Sukardi Hendrian   Chng Hui Ting   Chan Eric Chun Yong   Gong Zhiyuan   Lam Siew Hong  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 5, 2011-05 ,pp. : 579-589

Informa Healthcare

Access to resources Recommend Favorite